NCT03774667 is a clinical trial in Placenta Previa, sponsored by Maternal and Child Health Hospital of Foshan.

Who is sponsoring NCT03774667?

NCT03774667 is sponsored by Maternal and Child Health Hospital of Foshan.

What condition does NCT03774667 study?

NCT03774667 studies Placenta Previa.

Is NCT03774667 still recruiting?

NCT03774667 is currently status unknown. Last updated 9 June 2021.

Last reviewed 2021-06-09 · How we verify

NCT03774667

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Characteristics, Complications and Perinatal Outcomes in Placenta Previa Women

Status unknown Last updated 9 June 2021

What this trial tests

trial in Placenta Previa in 1,500 participants. Status unknown.

Timeline

1 January 2019

Primary endpoint
31 December 2021

30 June 2022

Quick facts

Lead sponsor	Maternal and Child Health Hospital of Foshan
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	1,500
Start date	1 January 2019
Primary completion	31 December 2021
Estimated completion	30 June 2022
Sites	1 location across China

Conditions studied

Placenta Previa — all drugs for Placenta Previa →

Sponsor

Maternal and Child Health Hospital of Foshan

Who can join

Adults 12 to 60, female only, with Placenta Previa. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aim to investigate the characteristics, complications and perinatal outcomes in pregnant women with placenta previa.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Placenta Previa

Currently open trials in the same condition.

NCT07025954 — Planned Delivery at 37 Versus 36 Weeks in Pregnancies With Placenta Previaand Accreta · NA · recruiting
NCT06849349 — EXAMINATION OF SOME MOLECULES IN PLACENTAS OF PATIENTS WITH PLACENTA PREVIA, PLACENTA PERCREATA · recruiting
NCT06867874 — Syncytiotrophoblast-derived Extracellular Vesicles in Placenta Previa and Accreta Spectrum · NA · recruiting

Other Maternal and Child Health Hospital of Foshan trials

Trials by the same sponsor.

NCT03181087 — Safety of Umbilical Cord Mesenchymal Stem Cell Local Intramuscular Injection for Treatment of Uterine Scars · Phase 1 · withdrawn
NCT05208515 — The Effect of Independent Obstetric Operating Room on Decision-to-delivery Interval for Emergency Cesarean Section · NA · unknown
NCT04034615 — The Long-term Effect of Perinatal Tissue Mesenchyme Stem Cells in the Treatment for Caesarean Section Scars · Phase 2 · withdrawn

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03774667 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Maternal and Child Health Hospital of Foshan
Last refreshed: 9 June 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03774667.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing